These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2176293)

  • 41. Central and peripheral involvement of endogenous opioid peptides in gastric protection in stressed rats.
    Scoto GM; Parenti C
    Pharmacology; 1996 Jan; 52(1):56-60. PubMed ID: 8966203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of opiate receptor drugs injected intracerebrally into the normovolemic and hypovolemic monkey.
    Kregel KC; Reynolds DG; Gurll NJ; Gisolfi CV
    Peptides; 1985; 6(6):1161-6. PubMed ID: 3010258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethanol regulated preference in rats.
    Heyman GM
    Psychopharmacology (Berl); 1993; 112(2-3):259-69. PubMed ID: 7871029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminergic mediation of reward produced by direct injection of enkephalin into the ventral tegmental area of the rat.
    Phillips AG; LePiane FG; Fibiger HC
    Life Sci; 1983 Dec; 33(25):2505-11. PubMed ID: 6417434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cataleptic effects of opiates following intrathecal administration.
    Watkins LR; Frenk H; Miller J; Mayer DJ
    Brain Res; 1984 May; 299(1):43-9. PubMed ID: 6326964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enkephalin analogue effects in the amygdala central nucleus on conditioned heart rate.
    Gallagher M; Kapp BS; Pascoe JP
    Pharmacol Biochem Behav; 1982 Aug; 17(2):217-22. PubMed ID: 6291066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid peptides within the midbrain periaqueductal gray suppress affective defense behavior in the cat.
    Shaikh MB; Shaikh AB; Siegel A
    Peptides; 1988; 9(5):999-1004. PubMed ID: 3244568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization.
    Kalivas PW; Taylor S; Miller JS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):537-43. PubMed ID: 2865357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of concurrent saccharin intake on ethanol consumption by high-alcohol-drinking (UChB) rats.
    Tampier L; Quintanilla ME
    Addict Biol; 2009 Jul; 14(3):276-82. PubMed ID: 19413565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ro 19-4603, a benzodiazepine receptor inverse agonist, attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference.
    Balakleevsky A; Colombo G; Fadda F; Gessa GL
    Alcohol Alcohol; 1990; 25(5):449-52. PubMed ID: 1965120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of the escape response by [D-Ala2]Met-enkephalin in the crab Chasmagnathus.
    Godoy AM; Maldonado H
    Pharmacol Biochem Behav; 1995 Mar; 50(3):445-51. PubMed ID: 7617684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [D-Ala2, Met5]-enkephalinamide: CNS-mediated inhibition of prostaglandin-stimulated intestinal fluid and ion transport in the rat.
    Quito FL; Brown DR
    Peptides; 1987; 8(6):1029-33. PubMed ID: 3441442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice.
    Phillips TJ; Wenger CD; Dorow JD
    Alcohol Clin Exp Res; 1997 Jun; 21(4):691-702. PubMed ID: 9194926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of D-Ala2 analogues of enkephalins on substance P-induced analgesia in rodents.
    Naranjo JR; Del Rio J
    Eur J Pharmacol; 1982 Aug; 82(3-4):213-6. PubMed ID: 6182008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central cardiovascular actions of D-Ala2-Met5-enkephalinamide in the rat: effects of naloxone and nucleus reticularis gigantocellularis lesion.
    Wong TM; Chan SH; Tse SY
    Neurosci Lett; 1984 May; 46(3):249-54. PubMed ID: 6377125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats.
    Leventhal L; Bodnar RJ
    Brain Res; 1996 Nov; 741(1-2):300-8. PubMed ID: 9001736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The in vitro and in vivo resistance of synthetic enkephalin analogs to three enkephalin-hydrolyzing enzymes.
    Ghoda K; Iwao K; Liu XF; Taniguchi T; Oka T
    Regul Pept; 1995 Sep; 59(1):87-96. PubMed ID: 12506418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adrenergic mediation of the intestinal antisecretory action of opiates administered into the central nervous system.
    Brown DR; Miller RJ
    J Pharmacol Exp Ther; 1984 Oct; 231(1):114-9. PubMed ID: 6387084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioiodinated [D-Ala2, Met5] enkephalin. Preparation, purification by high performance liquid chromatography and binding characteristics.
    Yeung CW
    Int J Pept Protein Res; 1984 Dec; 24(6):636-44. PubMed ID: 6099338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of single and repeated ethanol administration of hypothalamic opioid systems activity --an in vitro release study.
    Przewłocka B; Lason W
    Drug Alcohol Depend; 1991 Jan; 27(1):63-7. PubMed ID: 1851476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.